Sage Therapeutics, Inc. Stock
Stocks
SAGE
US78667J1088
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.680 USD | -0.23% |
|
-.--% | - |
| 25-07-31 | Supernus Pharmaceuticals Completes Sage Therapeutics Acquisition | MT |
| 25-07-31 | Sage Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 544M 477M 444M 407M 765M 52.35B 777M 5.27B 2.06B 25.73B 2.04B 2B 88.98B | P/E 2023 |
-2.39x | P/E 2024 | -0.82x |
|---|---|---|---|---|---|
| Enterprise Value | 50.98M 44.78M 41.64M 38.21M 71.79M 4.91B 72.9M 494M 193M 2.41B 191M 187M 8.35B | EV / Sales 2023 |
6.4x | EV / Sales 2024 | -3.89x |
| Free-Float |
99.75% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | -0.23% |
| 1 year | 8.68 |  | 8.81 |
| 3 years | 4.62 | | 37.16 |
| 5 years | 4.62 | | 59.99 |
| 10 years | 4.62 | | 195.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jack Khattar
PSD | President | 64 | 2025-07-30 |
Tammy J. Phinney
LAW | General Counsel | - | 2020-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jack Khattar
BRD | Director/Board Member | 64 | 2025-07-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/31/25 | Issuer sale | Chief Technology Officer | 72,961 | 0.1187% | ||
| 7/31/25 | Tender | Director | 43,499 | 0.0708% | ||
| 7/31/25 | Issuer sale | Chairman | 21,500 | 0.0350% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.23% | -.--% | -1.36% | -79.25% | 544M | |
| +0.93% | +6.97% | +59.60% | +68.35% | 57.28B | |
| -1.92% | +6.03% | +40.64% | +83.42% | 54.99B | |
| -0.46% | -1.29% | +2.86% | +428.78% | 23.18B | |
| -2.97% | -2.35% | -22.53% | -16.40% | 22.59B | |
| -0.36% | +5.73% | +24.13% | -6.24% | 20.46B | |
| -1.34% | +0.51% | +26.03% | -29.41% | 17.56B | |
| -1.44% | +5.67% | +38.77% | +504.71% | 15.67B | |
| -1.30% | -5.02% | +170.77% | +291.37% | 14.46B | |
| -0.50% | -0.98% | +21.43% | +180.07% | 13.92B | |
| Average | -0.96% | +1.15% | +36.03% | +142.54% | 24.06B | |
| Weighted average by Cap. | -0.87% | +2.09% | +39.61% | +133.01% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 86.46M 75.93M 70.62M 64.8M 122M 8.33B 124M 839M 328M 4.09B 325M 318M 14.15B | 41.24M 36.22M 33.69M 30.91M 58.08M 3.97B 58.98M 400M 156M 1.95B 155M 151M 6.75B |
| Net income | -541M -476M -442M -406M -763M -52.15B -774M -5.25B -2.05B -25.64B -2.03B -1.99B -88.64B | -401M -352M -327M -300M -564M -38.58B -573M -3.89B -1.52B -18.97B -1.5B -1.47B -65.59B |
| Net Debt | -748M -657M -611M -561M -1.05B -72.04B -1.07B -7.26B -2.83B -35.41B -2.81B -2.75B -122B | -493M -433M -402M -369M -694M -47.44B -704M -4.78B -1.87B -23.32B -1.85B -1.81B -80.63B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SAGE Stock
Select your edition
All financial news and data tailored to specific country editions
